Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure."
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers Windtree Therapeutics (NASDAQ:WINT) stock moved upwards by 63.5% to $0.28 during Wednesday’s regular session. The current volume…
Hoth Therapeutics Announces Increased Results Of Its Alzheimer’s Therapeutic HT-ALZ; Shows Cognitive Improvements In Alzheimer’s Disease Mouse Model And Results Show Reduced Anxiety And Improved Performance
HT-ALZ Therapeutic Shows Cognitive Improvements in Alzheimer's Disease Mouse Model and
Results Show Reduced Anxiety and Improved Performance
NEW YORK, Feb. 8, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc.
Dow Falls 300 Points On Last Trading Session of 2022; S&P 500 Down 1%
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 300 points on Friday.
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday’s Mid-Day Session
Gainers
Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.
US Stocks Open Lower; Dow Drops 250 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday.
Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday
Citigroup raised Ardelyx, Inc. (NASDAQ: ARDX) price target from $6 to $7. Citigroup analyst Yigal Nochomovitz maintained a Buy rating on the stock. Ardelyx shares rose 9.4% to $2.7685 on Friday.
EF Hutton Maintains Buy on Hoth Therapeutics, Lowers Price Target to $33
EF Hutton analyst Constantine Davides maintains Hoth Therapeutics (NASDAQ:HOTH) with a Buy and lowers the price target from $45 to $33.